Abstract
Adis Comment All drugs appearing in the Adis Profile Summary table have been selected based on information contained in R&D Insight'», a proprietary product of Adis International. As the emphasis of Drugs in R&D is on the clinical potential of new drugs, selection of agents for full profile is based on the extensiveness of available data. Information on all drugs in clinical development, as identified from R&D Insight'», is included in the summary table. Information and/or profiles of agents in preclinical development may be included as appropriate.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have